Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
YH Chan, TF Chao, SW Chen, HF Lee, YH Yeh… - Heart rhythm, 2020 - Elsevier
Background Off-label dosing non–vitamin K antagonist oral anticoagulants (NOACs) are
commonly prescribed for Asian patients with atrial fibrillation (AF). Objective The purpose of …
commonly prescribed for Asian patients with atrial fibrillation (AF). Objective The purpose of …
Effectiveness and safety of off-label dosing of non–vitamin K antagonist anticoagulant for atrial fibrillation in Asian patients
KN Lee, JI Choi, KY Boo, DY Kim, YG Kim, SK Oh… - Scientific reports, 2020 - nature.com
Non–vitamin K antagonist anticoagulants (NOACs) have been used to prevent
thromboembolism in patients with atrial fibrillation (AF) and shown favorable clinical …
thromboembolism in patients with atrial fibrillation (AF) and shown favorable clinical …
Pattern and impact of off-label underdosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation who are indicated for standard dosing
MS Cho, JE Yun, JJ Park, YJ Kim, J Lee, H Kim… - The American Journal of …, 2020 - Elsevier
With safety concerns about increasing bleeding, off-label underdosing of non-vitamin K
antagonist anticoagulants (NOACs) is common in East Asian patients with atrial fibrillation …
antagonist anticoagulants (NOACs) is common in East Asian patients with atrial fibrillation …
Outcomes after use of standard-and low-dose non–vitamin k oral anticoagulants in Asian patients with atrial fibrillation
MS Cho, JE Yun, JJ Park, YJ Kim, J Lee, H Kim… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Limited data are available describing the relative effectiveness,
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …
Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials
Aims Non-vitamin K antagonist oral anticoagulants (NOACs) require dose reductions
according to patient or clinical factors for patients with atrial fibrillation (AF). In this meta …
according to patient or clinical factors for patients with atrial fibrillation (AF). In this meta …
Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta …
Objective There has been limited systematic evaluation of outcomes and drivers of
inappropriate non-vitamin K antagonist oral anticoagulants (NOACs) dosing among patients …
inappropriate non-vitamin K antagonist oral anticoagulants (NOACs) dosing among patients …
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies
Z Xue, H Zhang - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Several randomized trials and real-world studies have reported
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
the efficacy and safety of non–vitamin K antagonist oral anticoagulants (NOACs) in Asian …
Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation
HT Yu, PS Yang, E Jang, TH Kim, JS Uhm… - Journal of the …, 2020 - Am Heart Assoc
Background Dose adjustment of non‐vitamin K antagonist oral anticoagulants (NOAC s) is
indicated in some patients with atrial fibrillation (AF), based on selected patient factors or …
indicated in some patients with atrial fibrillation (AF), based on selected patient factors or …
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French …
Objectives To describe (i) the trend in oral anticoagulant (OAC) use following the
introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke …
introduction of non-vitamin K antagonist oral anticoagulant (NOAC) therapy for stroke …
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation
Background and Purpose—There are limited real-world data comparing the effectiveness
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …